We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 1,072

Federal Circuit’s recent primer on patent-eligibility
  • Foley & Lardner LLP
  • USA
  • July 6 2016

A method of producing a desired population of multi-cryopreserved hepatocytes was held to be patent-eligible because the challenged claims did not


Supreme Court Declines Sequenom Review
  • Foley & Lardner LLP
  • USA
  • July 5 2016

Last week the United States Supreme Court denied Sequenom’s petition to review the Federal Circuit’s holding in Sequenom Inc. v. Ariosa Diagnostic


Senate Judiciary Introduces CREATES Act To Expedite Access To Affordable Drugs
  • Foley & Lardner LLP
  • USA
  • July 5 2016

Following months of public outcry and Congressional probes into significant drug price increases, the Senate Judiciary Committee introduced


Supreme Court Declines Sequenom Review
  • Foley & Lardner LLP
  • USA
  • July 4 2016

Last week the United States Supreme Court denied Sequenom's petition to review the Federal Circuit's holding in Sequenom Inc. v. Ariosa Diagnostic


Court Invalidates Improper Multiple Dependent Claims
  • Foley & Lardner LLP
  • USA
  • June 30 2016

In Trustees of the University of Pennsylvania v. Eli Lilly and Co., the U.S. District Court for the Eastern District of Pennsylvania refused to


Supreme Court Deals Blow To Diagnostic Method Patents, Denies Cert In Sequenom
  • Foley & Lardner LLP
  • USA
  • June 28 2016

“If you can’t say something nice, don’t say anything at all” can be good words to live by, but in the context of the Supreme Court’s denial of


Supreme Court Declines to Review Sequenom Ruling
  • Foley & Lardner LLP
  • USA
  • June 27 2016

The U.S. Supreme Court has denied certiorari in Sequenom, Inc. v. Ariosa Diagnostics, Inc. (No. 15-1182), declining to review the Federal Circuit’s


Will the Supreme Court Clarify Patent-Eligibility?
  • Foley & Lardner LLP
  • USA
  • June 26 2016

The United States Supreme Court is set to render its decision on the grant or denial of Sequenom, Inc.'s ("Sequenom's") petition for writ of


U.S. Supreme Court Strengthens Patents
  • Foley & Lardner LLP
  • USA
  • June 23 2016

The decision earlier this month in the case of Halo v Pulse, will give owners of US patents a greater likelihood of being awarded enhanced damages


CAFC Upholds Same Day Continuation Applications
  • Foley & Lardner LLP
  • USA
  • June 22 2016

The Federal Circuit decided not to disturb the “longstanding administrative construction” of 35 USC 120 that permits the filing of a continuation